Total Payments
$16,038
2024 Payments
$1,611
Companies
57
Transactions
895
Medicare Patients
6,035
Medicare Billing
$362,968
Payment Breakdown by Category
Food & Beverage$14,756 (92.0%)
Consulting$1,200 (7.5%)
Other$53.04 (0.3%)
Education$29.18 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,756 | 889 | 92.0% |
| Consulting Fee | $1,200 | 1 | 7.5% |
| Debt forgiveness | $53.04 | 1 | 0.3% |
| Education | $29.18 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,306 | 130 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,529 | 10 | $0 (2021) |
| Lilly USA, LLC | $1,338 | 104 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,257 | 66 | $0 (2023) |
| GlaxoSmithKline, LLC. | $940.63 | 62 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $888.52 | 57 | $0 (2024) |
| ABBVIE INC. | $816.40 | 56 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $593.92 | 41 | $0 (2024) |
| Amgen Inc. | $495.85 | 36 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $473.54 | 33 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,611 | 89 | Novo Nordisk Inc ($250.68) |
| 2023 | $1,699 | 102 | AbbVie Inc. ($323.23) |
| 2022 | $1,895 | 103 | Novo Nordisk Inc ($335.58) |
| 2021 | $3,862 | 123 | Biohaven Pharmaceuticals, Inc. ($1,515) |
| 2020 | $1,175 | 76 | Novo Nordisk Inc ($308.53) |
| 2019 | $1,985 | 131 | Novo Nordisk Inc ($353.25) |
| 2018 | $2,120 | 139 | AstraZeneca Pharmaceuticals LP ($273.27) |
| 2017 | $1,691 | 132 | GlaxoSmithKline, LLC. ($252.40) |
All Payment Transactions
895 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Endocrinology | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: VACCINE | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Biological | ||||||
| 11/21/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Oncology | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Cardio-renal | ||||||
| 10/14/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Obesity | ||||||
| 10/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $8.31 | General |
| 10/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $111.28 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,066 | 1,243 | $189,210 | $69,225 |
| 2022 | 22 | 1,638 | 1,895 | $288,012 | $114,726 |
| 2021 | 22 | 1,627 | 1,844 | $234,912 | $91,315 |
| 2020 | 29 | 1,704 | 1,933 | $220,918 | $87,701 |
Total Patients
6,035
Total Services
6,915
Medicare Billing
$362,968
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 194 | 326 | $95,192 | $29,251 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 131 | 131 | $39,038 | $16,845 | 43.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 61 | $12,566 | $3,880 | 30.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $5,400 | $3,380 | 62.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 36 | 36 | $6,768 | $2,719 | 40.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 37 | 37 | $4,514 | $2,658 | 58.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $4,512 | $2,005 | 44.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 108 | 120 | $4,800 | $1,574 | 32.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 120 | 134 | $4,154 | $1,387 | 33.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 38 | $1,900 | $1,189 | 62.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 15 | 15 | $1,965 | $871.80 | 44.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 42 | 42 | $1,806 | $783.30 | 43.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 55 | 62 | $1,550 | $590.24 | 38.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 26 | 28 | $1,400 | $460.88 | 32.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $600.00 | $375.36 | 62.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 16 | 16 | $640.00 | $302.72 | 47.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 30 | 32 | $640.00 | $243.52 | 38.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 43 | 43 | $516.00 | $243.38 | 47.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 43 | 43 | $473.00 | $218.44 | 46.2% |
| 90471 | Administration of vaccine | Office | 2023 | 11 | 13 | $507.00 | $162.60 | 32.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 17 | 17 | $204.00 | $55.68 | 27.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 13 | $65.00 | $28.60 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 220 | 406 | $118,552 | $37,416 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 171 | 171 | $50,958 | $22,935 | 45.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 193 | 193 | $36,284 | $15,946 | 43.9% |
About Dr. Barry Troyan, MD
Dr. Barry Troyan, MD is a Internal Medicine healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295733483.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barry Troyan, MD has received a total of $16,038 in payments from pharmaceutical and medical device companies, with $1,611 received in 2024. These payments were reported across 895 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($14,756).
As a Medicare-enrolled provider, Troyan has provided services to 6,035 Medicare beneficiaries, totaling 6,915 services with total Medicare billing of $362,968. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Katy, TX
- Active Since 07/12/2005
- Last Updated 05/21/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1295733483
Products in Payments
- NURTEC ODT (Drug) $1,688
- Ozempic (Drug) $1,155
- FARXIGA (Drug) $894.04
- Kerendia (Drug) $593.92
- JARDIANCE (Drug) $585.78
- TRULICITY (Drug) $556.76
- VRAYLAR (Drug) $478.74
- Vascepa (Drug) $432.32
- XIFAXAN (Drug) $365.59
- XARELTO (Drug) $365.37
- TRELEGY ELLIPTA (Drug) $349.51
- MYRBETRIQ (Drug) $339.23
- RYBELSUS (Drug) $329.65
- MOUNJARO (Drug) $302.78
- Azstarys (Drug) $265.02
- UBRELVY (Drug) $249.91
- NEXLETOL (Drug) $237.95
- Saxenda (Drug) $231.35
- TRADJENTA (Drug) $229.45
- Rybelsus (Drug) $221.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Katy
Dharmendra Verma, M.d, M.D
Internal Medicine — Payments: $43,959
Internal Medicine $43,959
Dr. Syed Zaidi, M.d, M.D
Internal Medicine — Payments: $20,985
Internal Medicine $20,985
Dr. Mukesh Mehta, M.d, M.D
Internal Medicine — Payments: $18,042
Internal Medicine $18,042
Dr. Moo Chung, M.d, M.D
Internal Medicine — Payments: $17,384
Internal Medicine $17,384
Roger Campana, Md, MD
Internal Medicine — Payments: $17,323
Internal Medicine $17,323
Viswanath Kalapatapu, M.d, M.D
Internal Medicine — Payments: $14,406
Internal Medicine $14,406